Endoscopic Ultrasound-guided Biopsy of Liver Tumors

In Vivo. 2022 Mar-Apr;36(2):890-897. doi: 10.21873/invivo.12778.

Abstract

Background/aim: Endoscopic ultrasound (EUS)-guided liver tumor biopsy has some advantages over the percutaneous and surgical route and, in many cases, should be preferred. The aim of this study was to evaluate the role of EUS-fine needle aspiration (FNA) in the diagnosis of liver tumors with an emphasis on its diagnostic accuracy and histological quality of the acquired specimen.

Patients and methods: We followed 30 consecutive patients who underwent liver tumor biopsy using EUS guidance. Tissue was acquired using a 22-gauge FNA needle.

Results: In 97% of patients, the results of EUS-FNA were adequate for diagnosis. In one case, the pathologist recommended a repeat biopsy. The acquired specimen was a core fragment in 81% of cases while in 19% of cases the specimen was fragmented and subsequently used as a cell block. No complications were reported.

Conclusion: EUS-FNA is characterized by a high success rate on the acquisition of good-quality tissue specimens, a low rate of complications, and decreased patient discomfort. This procedure should be especially considered in the case of liver lesions that are inaccessible via the percutaneous route or when concurrent biopsies are required for accurate diagnosis.

Keywords: Endoscopic ultrasound-fine needle aspiration (EUS-FNA); focal liver lesions; liver biopsy.

MeSH terms

  • Endoscopic Ultrasound-Guided Fine Needle Aspiration / methods
  • Endosonography / methods
  • Humans
  • Image-Guided Biopsy / methods
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / pathology
  • Pancreatic Neoplasms* / pathology